CRT-100.58 Meta-Analysis of Genotype-Guided Antiplatelet Therapy in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

2020 
Previous studies have shown similar adverse events in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) and treated with P2Y12 Inhibitors based on genotype guidance compared to standard treatment. However, these studies were underpowered with lower-than-
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []